Respiratory viruses (RVs), including but not limited to influenza virus, respiratory syncytial virus, coronavirus, rhinovirus, parainfluenza virus, adenovirus, and human metapneumovirus, can lead to severe diseases including bronchiolitis and pneumonia or/and to exacerbations of asthma and chronic obstructive pulmonary disease. Lung airway epithelial cells and mucosal immune cells are the primary cells for RVs. Following viral infection, these cells generate a range of mediators, including type I interferon (IFN), proinflammatory cytokines, and chemokines, which not only have pivotal roles in virus control but also determine the development of inflammation and disease. Given that vaccines are not available for RVs other than influenza virus, there is a critical need for the understanding of the interactions between RV and host innate immunity and the development of effective therapies limiting the severity of inflammation caused by RV infection.
This special issue presents five original research articles on host immune responses to different RVs, including influenza A virus (IAV), adenovirus, herpesvirus, and rhinovirus. Human adenovirus causes the most community-acquired pneumonia in infants and children with significant morbidity and mortality. Viruses are known to modulate host microRNAs (miRNAs), which are critical for viral replication and host immune response. However, the profiling of miRNA in children infected with adenovirus has not been reported yet. In this issue, F. Huang et al. examined the miRNA expression in the whole blood of adenovirus-infected pneumonia children and healthy controls by RNA sequencing. Their studies showed a distinct miRNA expression profile in adenovirus-infected children highlighted with the top three unregulated miRNAs (hsa-miR-127-3p, hsa-miR-493-5p, and hsa-miR-409-3p). Analysis of the host target genes of the microRNAs revealed that most target genes are involved in the MAPK signaling pathway and innate immune response. The microRNA profiling will not only help understand the role of miRNAs in modulating the host response to adenovirus infection but also provide potential biomarkers for adenovirus-infected pneumonia.
It has been well established that retinoic acid-inducible gene I (RIG-I) is a cytosolic sensor for RNA viruses, which binds viral RNAs, such as double-stranded RNA and 5 ′ -triphosphate RNA. Recent studies show that CD4+ stem cell-like memory T cells (TSCMs) are a distinct memory T cell subset and preferentially reside in the bone marrow (BM). However, the existence and function of CD4+ TSCMs in a mouse, especially at the anatomical site of CD4+ TSCMs, were not well characterized. In this special topic issue, K. Wu et al. provided evidence that the BM acts as a hub for the relocation of most of antigen-specific CD4+ TSCMs. Furthermore, BM-resident TSCMs showed higher activity in inducing antibodies against influenza infection when compared with the spleen-resident TSCMs in mice. These findings may provide insights for future implications of immunotherapy against influenza.
Bovine herpesvirus type 1 (BoHV-1) infection causes inflammation in the respiratory tract and reproductive system in cattle of all ages and breeds. How BoHV-1 infection leads to inflammation is not well elucidated. X. Fu et al. found that BoHV-1 infection induces overproduction of reactive oxidative species (ROS), which are inflammatory mediators. Their studies further showed that interruption of the mitochondrial respiratory chain (RC) complexes by different chemicals reduced virus productive infection, suggesting that the integrity of RC complexes is critical for BoHV-1 replication. The virus infection significantly regulated the expression of various genes involved in the mitochondrial respiratory chain, antioxidant enzymes, and mitochondrial biogenesisrelated signalings, such as MTCO1 SOD1/2, TFAM, and NRF1/2. These findings will advance the understanding of the mechanisms of BoHV-1 infection-induced ROS production and mitochondrial damage.
Overall, these original research articles will improve our knowledge of immune responses to RV infection, provide insights into the future design of effective antivirals, and pave the avenues for a rational basis for the development of potential therapeutic strategies.
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